• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mutations in Helicobacter pylori porD and oorD genes may contribute to furazolidone resistance.幽门螺杆菌porD和oorD基因的突变可能导致对呋喃唑酮耐药。
Croat Med J. 2006 Jun;47(3):410-5.
2
Resistance of to furazolidone and levofloxacin: A viewpoint.对呋喃唑酮和左氧氟沙星的耐药性:一种观点。
World J Gastroenterol. 2017 Oct 7;23(37):6920-6922. doi: 10.3748/wjg.v23.i37.6920.
3
[Antibiotic resistance of Helicobacter pylori].[幽门螺杆菌的抗生素耐药性]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007 Jun;32(3):447-50.
4
Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens.基于双引物寡核苷酸的多重PCR用于检测幽门螺杆菌及通过胃活检标本测定克拉霉素耐药性
Helicobacter. 2009 Feb;14(1):22-8. doi: 10.1111/j.1523-5378.2009.00654.x.
5
Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCR-based denaturing HPLC assay.使用基于聚合酶链反应的变性高效液相色谱分析法快速检测幽门螺杆菌对克拉霉素的耐药性。
J Antimicrob Chemother. 2006 Jan;57(1):71-8. doi: 10.1093/jac/dki406. Epub 2005 Nov 11.
6
Oligonucleotide microarray: a new rapid method for screening the 23S rRNA gene of Helicobacter pylori for single nucleotide polymorphisms associated with clarithromycin resistance.寡核苷酸微阵列:一种用于筛查幽门螺杆菌23S rRNA基因中与克拉霉素耐药相关单核苷酸多态性的新型快速方法。
J Gastroenterol Hepatol. 2008 Jan;23(1):126-31. doi: 10.1111/j.1440-1746.2007.04900.x.
7
Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.用于分析幽门螺杆菌菌株对克拉霉素敏感性的改良等位基因特异性引物聚合酶链反应方法
J Gastroenterol Hepatol. 2007 Nov;22(11):1810-5. doi: 10.1111/j.1440-1746.2007.04919.x.
8
[In vitro activity of furazolidone and nitrofurantoin in Helicobacter pylori clinical isolates and study of mutation rate].[呋喃唑酮和呋喃妥因对幽门螺杆菌临床分离株的体外活性及突变率研究]
Rev Esp Quimioter. 2005 Dec;18(4):313-8.
9
Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene.幽门螺杆菌中涉及23S rRNA基因第五结构域的新型基因型。
Helicobacter. 2007 Oct;12(5):505-9. doi: 10.1111/j.1523-5378.2007.00506.x.
10
[Real-time PCR assay for rapid detection of clarithromycin-resistant helicobacter pylori in gastric biopsy specimens].[实时聚合酶链反应检测胃活检标本中耐克拉霉素幽门螺杆菌的快速检测法]
Z Gastroenterol. 2004 Dec;42(12):1371-5. doi: 10.1055/s-2004-813313.

引用本文的文献

1
Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective.幽门螺杆菌的抗生素耐药性:遗传学和生理学视角
Gut Pathog. 2025 May 23;17(1):35. doi: 10.1186/s13099-025-00704-5.
2
Furazolidone susceptibility of Helicobacter pylori isolated from patients with gastroduodenal diseases in Colombia.从哥伦比亚胃十二指肠疾病患者中分离出的幽门螺杆菌对呋喃唑酮的敏感性
Rev Inst Med Trop Sao Paulo. 2025 Apr 4;67:e20. doi: 10.1590/S1678-9946202567020. eCollection 2025.
3
Point Mutations in Furazolidone and Rifampicin Resistance Genes in Strains from Colombia.哥伦比亚菌株中呋喃唑酮和利福平耐药基因的点突变
Antibiotics (Basel). 2024 Jul 12;13(7):643. doi: 10.3390/antibiotics13070643.
4
Exploring Alternative Treatment Choices for Multidrug-Resistant Clinical Strains of in Mongolia.探索蒙古耐多药临床菌株的替代治疗选择。
Microorganisms. 2023 Nov 24;11(12):2852. doi: 10.3390/microorganisms11122852.
5
Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice.幽门螺杆菌的抗生素耐药性:从潜在的生物分子机制到临床实践。
J Clin Lab Anal. 2023 Apr;37(7):e24885. doi: 10.1002/jcla.24885. Epub 2023 Apr 23.
6
Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.幽门螺杆菌感染、实验室诊断及抗菌耐药性:临床相关性视角。
Clin Microbiol Rev. 2022 Sep 21;35(3):e0025821. doi: 10.1128/cmr.00258-21. Epub 2022 Apr 11.
7
A retrospective study of the antibiotic-resistant phenotypes and genotypes of strains in China.中国菌株抗生素耐药表型与基因型的回顾性研究。
Am J Cancer Res. 2021 Oct 15;11(10):5027-5037. eCollection 2021.
8
Safety of furazolidone-containing regimen in infection: a systematic review and meta-analysis.呋喃唑酮方案治疗感染的安全性:系统评价和荟萃分析。
BMJ Open. 2020 Oct 19;10(10):e037375. doi: 10.1136/bmjopen-2020-037375.
9
The Involvement of the Gene in Virulence of .基因在 致病力中的作用。
Front Cell Infect Microbiol. 2018 Aug 20;8:285. doi: 10.3389/fcimb.2018.00285. eCollection 2018.
10
Resistance of to furazolidone and levofloxacin: A viewpoint.对呋喃唑酮和左氧氟沙星的耐药性:一种观点。
World J Gastroenterol. 2017 Oct 7;23(37):6920-6922. doi: 10.3748/wjg.v23.i37.6920.

本文引用的文献

1
Ancient genes in contemporary persistent microbial pathogens.当代持续性微生物病原体中的古老基因。
Biol Bull. 2006 Feb;210(1):1-9. doi: 10.2307/4134531.
2
Of microbe and man: determinants of Helicobacter pylori-related diseases.微生物与人类:幽门螺杆菌相关疾病的决定因素
FEMS Microbiol Rev. 2006 Jan;30(1):131-56. doi: 10.1111/j.1574-6976.2005.00006.x.
3
A furazolidone-based quadruple therapy for Helicobacter pylori retreatment in patients with peptic ulcer disease.一种基于呋喃唑酮的四联疗法用于消化性溃疡疾病患者幽门螺杆菌再治疗。
Clinics (Sao Paulo). 2005 Dec;60(6):485-8. doi: 10.1590/s1807-59322005000600010. Epub 2005 Dec 12.
4
[Treatment of Helicobacter pylori infection].[幽门螺杆菌感染的治疗]
Korean J Gastroenterol. 2005 Sep;46(3):172-80.
5
Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.新型合成药物NE-2001对幽门螺杆菌的杀菌及形态学作用
Antimicrob Agents Chemother. 2005 Aug;49(8):3468-73. doi: 10.1128/AAC.49.8.3468-3473.2005.
6
Eradication of Helicobacter pylori: recent advances in treatment.幽门螺杆菌的根除:治疗方面的最新进展
Fundam Clin Pharmacol. 2005 Aug;19(4):421-7. doi: 10.1111/j.1472-8206.2005.00340.x.
7
Structural basis of 5-nitroimidazole antibiotic resistance: the crystal structure of NimA from Deinococcus radiodurans.5-硝基咪唑类抗生素耐药性的结构基础:耐辐射球菌NimA的晶体结构
J Biol Chem. 2004 Dec 31;279(53):55840-9. doi: 10.1074/jbc.M408044200. Epub 2004 Oct 18.
8
Nitazoxanide in treatment of Helicobacter pylori: a clinical and in vitro study.硝唑尼特治疗幽门螺杆菌:一项临床及体外研究。
Antimicrob Agents Chemother. 2003 Dec;47(12):3780-3. doi: 10.1128/AAC.47.12.3780-3783.2003.
9
The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections.既往抗菌药物使用、抗菌药物耐药性与幽门螺杆菌感染治疗结局之间的关系。
Ann Intern Med. 2003 Sep 16;139(6):463-9. doi: 10.7326/0003-4819-139-6-200309160-00008.
10
The Entner-Doudoroff pathway has little effect on Helicobacter pylori colonization of mice.恩特纳-杜德洛夫途径对幽门螺杆菌在小鼠体内的定殖影响很小。
Infect Immun. 2003 May;71(5):2920-3. doi: 10.1128/IAI.71.5.2920-2923.2003.

幽门螺杆菌porD和oorD基因的突变可能导致对呋喃唑酮耐药。

Mutations in Helicobacter pylori porD and oorD genes may contribute to furazolidone resistance.

作者信息

Su Zhaoliang, Xu Huaxi, Zhang Chiyu, Shao Shihe, Li Liangju, Wang Hua, Wang Huifang, Qiu Gufeng

机构信息

Department of Microbiology and Immunology, Institute of Clinical Laboratory Science, Jiangsu University, Zhenjiang, China.

出版信息

Croat Med J. 2006 Jun;47(3):410-5.

PMID:16758519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2080422/
Abstract

AIM

To determine the rate of furazolidone resistance of Helicobacter pylori (H. pylori) isolated from gastric biopsy specimens and to explore the relationship between genetic mutations in porD and oorD genes of H. pylori and its resistance to the antibiotic.

METHODS

Gastric biopsy was performed in 83 adult patients aged 31-77 years with gastric complaints. H. pylori was isolated from biopsy specimens of 46 patients. E-test and 2-fold agar dilution method were used to determine the rate of H. pylori resistance to furazolidone. The genes porD and oorD from susceptible and resistant isolates were amplified by polymerase chain reaction (PCR), and their PCR products were sequenced.

RESULTS

Resistance to furazolidone was found in 8.7% of H. pylori isolates and 6 mutations were detected in porD and oorD genes of the resistant isolates. Three mutations--G353A, A356G, and C357T--occurred in porD and the other mutations--A041G, A122G, C349A(G)--occurred in oorD genes.

CONCLUSIONS

Changes in 6 amino acids may be associated with the resistance of H. pylori to furazolidone.

摘要

目的

确定从胃活检标本中分离出的幽门螺杆菌(H. pylori)对呋喃唑酮的耐药率,并探讨幽门螺杆菌porD和oorD基因的基因突变与其对抗生素耐药性之间的关系。

方法

对83例年龄在31至77岁有胃部不适症状的成年患者进行胃活检。从46例患者的活检标本中分离出幽门螺杆菌。采用E-test法和2倍琼脂稀释法测定幽门螺杆菌对呋喃唑酮的耐药率。通过聚合酶链反应(PCR)扩增敏感和耐药菌株的porD和oorD基因,并对其PCR产物进行测序。

结果

在8.7%的幽门螺杆菌分离株中发现对呋喃唑酮耐药,在耐药菌株的porD和oorD基因中检测到6个突变。3个突变——G353A、A356G和C357T——发生在porD基因中,其他突变——A041G、A122G、C349A(G)——发生在oorD基因中。

结论

6个氨基酸的变化可能与幽门螺杆菌对呋喃唑酮的耐药性有关。